X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12995) 12995
Publication (1501) 1501
Book Review (313) 313
Book Chapter (93) 93
Newsletter (58) 58
Conference Proceeding (26) 26
Book / eBook (21) 21
Dissertation (19) 19
Reference (5) 5
Magazine Article (4) 4
Data Set (2) 2
Paper (2) 2
Transcript (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (7404) 7404
index medicus (7192) 7192
humans (6765) 6765
male (5519) 5519
angiotensin (3838) 3838
rats (3796) 3796
hypertension (3556) 3556
female (2710) 2710
pharmacology & pharmacy (2164) 2164
renin-angiotensin system (2119) 2119
angiotensin ii (2100) 2100
angiotensin-ii (2081) 2081
angiotensin ii type 1 receptor blockers - pharmacology (1989) 1989
mice (1796) 1796
oxidative stress (1744) 1744
peripheral vascular disease (1734) 1734
blood-pressure (1709) 1709
middle aged (1626) 1626
blood pressure - drug effects (1573) 1573
hypertension - drug therapy (1514) 1514
physiology (1501) 1501
cardiac & cardiovascular systems (1479) 1479
rats, sprague-dawley (1446) 1446
endocrinology & metabolism (1417) 1417
angiotensin-converting enzyme inhibitors - therapeutic use (1384) 1384
expression (1347) 1347
blood pressure (1333) 1333
renin-angiotensin system - drug effects (1319) 1319
angiotensin ii - pharmacology (1315) 1315
angiotensin ii - metabolism (1256) 1256
receptor, angiotensin, type 1 - metabolism (1225) 1225
diabetes (1221) 1221
aged (1190) 1190
angiotensin ii type 1 receptor blockers - therapeutic use (1158) 1158
disease models, animal (1138) 1138
risk factors (1120) 1120
urology & nephrology (1088) 1088
medicine & public health (1085) 1085
hypertension - physiopathology (1083) 1083
tetrazoles - pharmacology (1044) 1044
adult (1040) 1040
physiological aspects (1024) 1024
losartan - pharmacology (1022) 1022
research (1021) 1021
antihypertensive agents - therapeutic use (1012) 1012
renin-angiotensin system - physiology (997) 997
analysis (984) 984
cells, cultured (982) 982
heart failure (963) 963
rats, wistar (959) 959
inflammation (939) 939
angiotensin-converting enzyme inhibitors - pharmacology (929) 929
rodents (901) 901
cell biology (889) 889
enzymes (870) 870
health aspects (833) 833
losartan (833) 833
activation (829) 829
article (829) 829
fibrosis (808) 808
signal transduction (808) 808
medicine (795) 795
treatment outcome (791) 791
cardiology (782) 782
biochemistry & molecular biology (772) 772
renin (771) 771
antihypertensive agents - pharmacology (764) 764
system (764) 764
heart-failure (761) 761
dose-response relationship, drug (758) 758
benzimidazoles - pharmacology (755) 755
time factors (738) 738
internal medicine (729) 729
receptor (725) 725
smooth-muscle-cells (690) 690
hypertension - metabolism (686) 686
aldosterone (685) 685
medicine, research & experimental (681) 681
inhibition (675) 675
kidney - metabolism (673) 673
drug therapy (672) 672
imidazoles - pharmacology (668) 668
mice, inbred c57bl (666) 666
heart (662) 662
care and treatment (659) 659
nitric oxide (654) 654
nitric-oxide (644) 644
mortality (643) 643
gene expression (634) 634
insulin resistance (632) 632
proteins (625) 625
tetrazoles - therapeutic use (624) 624
angiotensin receptor antagonists (621) 621
angiotensin-converting enzyme (618) 618
drug therapy, combination (608) 608
myocardial-infarction (606) 606
atherosclerosis (594) 594
rna, messenger - metabolism (593) 593
valsartan (584) 584
kidney - drug effects (570) 570
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13082) 13082
Japanese (128) 128
Chinese (34) 34
German (10) 10
Russian (10) 10
Spanish (7) 7
French (5) 5
Korean (4) 4
Hungarian (3) 3
Italian (3) 3
Polish (3) 3
Czech (2) 2
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7650, pp. 327 - 332
Journal Article
Brain Research, ISSN 0006-8993, 2014, Volume 1583, Issue 1, pp. 132 - 140
Abstract Angiotensin II (Ang II) stimulates water and saline intakes when injected into the brain of rats. This arises from activation of the AT1 Ang II... 
Neurology | Hypertension | Brain | Desensitization | Saline intake | Angiotensin | Water intake | Radioligand | AT1 angiotensin receptors | Thirst | At1 angiotensin receptors | Brain hypertension | BEHAVIORAL DESENSITIZATION | PATHWAYS | SYSTEM | ACTIVATION | AT angiotensin receptors | PHOSPHORYLATION | RECEPTOR | NEUROSCIENCES | GUANYL NUCLEOTIDES | EXPRESSION | GUANINE-NUCLEOTIDES | Iodine Radioisotopes | Angiotensin II - administration & dosage | Preoptic Area - drug effects | Sodium Chloride, Dietary - administration & dosage | Male | Preoptic Area - physiopathology | Angiotensin II Type 1 Receptor Blockers - metabolism | Subfornical Organ - drug effects | Radioligand Assay | Radiopharmaceuticals | 1-Sarcosine-8-Isoleucine Angiotensin II - metabolism | Drinking Water - administration & dosage | Subfornical Organ - metabolism | Receptor, Angiotensin, Type 2 - agonists | Angiotensin II - pharmacology | Angiotensin II - metabolism | Drinking - physiology | Angiotensin II - analogs & derivatives | Rats, Sprague-Dawley | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Receptor, Angiotensin, Type 2 - metabolism | Central Nervous System Agents - pharmacology | Paraventricular Hypothalamic Nucleus - metabolism | Drinking - drug effects | Angiotensin II Type 2 Receptor Blockers - metabolism | G proteins | Pharmacy | radioligand | thirst | water intake | saline intake | desensitization
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 09/2015, Volume 50, Issue 9, pp. 1068 - 1075
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 02/2012, Volume 40, Issue 2, pp. 374 - 380
Journal Article
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 08/2016, Volume 97, pp. 180 - 190
Journal Article
Science, ISSN 0036-8075, 4/2011, Volume 332, Issue 6027, pp. 361 - 365
Angiotensin II (AngII) mediates progression of aortic aneurysm, but the relative contribution of its type 1 (AT1) and type 2 (AT2) receptors remains unknown.... 
Connective tissues | Receptors | Root growth | Medical treatment | REPORTS | Aneurysms | Placebos | Aorta | Mice | Aortic aneurysm | Marfan syndrome | PATHOGENESIS | ACTIVATION | MECHANISM | MULTIDISCIPLINARY SCIENCES | MARFAN-SYNDROME | MOUSE MODEL | GROWTH | SMOOTH-MUSCLE-CELLS | BLOCKADE | CONTRIBUTES | EXPRESSION | Aortic Aneurysm - metabolism | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Aortic Rupture - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | MAP Kinase Signaling System | Marfan Syndrome - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aortic Rupture - prevention & control | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Aortic Aneurysm - pathology | Aortic Aneurysm - prevention & control | Disease Models, Animal | Receptor, Angiotensin, Type 2 - genetics | Angiotensin II - metabolism | Signal Transduction | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Losartan - pharmacology | Aortic Rupture - pathology | Disease Progression | Mice, Knockout | Animals | Enalapril - pharmacology | Receptor, Angiotensin, Type 2 - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Aortic Aneurysm - drug therapy | Losartan - therapeutic use | Marfan Syndrome - metabolism | Marfan Syndrome - pathology | Transforming Growth Factor beta - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Aortic aneurysms | Development and progression | Genetic aspects | Health aspects | Angiotensin | Signal transduction | Peptides | Cellular biology | Coronary vessels | Rodents
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 03/2010, Volume 298, Issue 3, pp. F683 - F691
Naito T, Ma L-J, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects... 
Podocyte | Plasminogen activator inhibitor-1 | PHYSIOLOGY | AT RECEPTOR | SUBTOTALLY NEPHRECTOMIZED RATS | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | GLOMERULAR INJURY | BLOOD-PRESSURE | SHP-1 TYROSINE PHOSPHATASE | plasminogen activator inhibitor-1 | podocyte | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | SMOOTH-MUSCLE-CELLS | URETERAL OBSTRUCTION | ENDOTHELIAL GROWTH-FACTOR | Kidney Diseases - physiopathology | Phosphorylation | Kidney - pathology | Apoptosis - drug effects | Male | Proteinuria - pathology | RNA, Messenger - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Glomerular Filtration Rate - drug effects | Kidney - metabolism | Nephrectomy | Plasminogen Activator Inhibitor 1 - metabolism | Time Factors | Blood Pressure - drug effects | Plasminogen Activator Inhibitor 1 - genetics | Fibrinolysin - metabolism | Kidney - physiopathology | Disease Models, Animal | Kidney Diseases - metabolism | Kidney - surgery | Kidney - drug effects | Angiotensin II - metabolism | Kidney Diseases - pathology | Cells, Cultured | Losartan - pharmacology | Kidney Diseases - drug therapy | Proteinuria - metabolism | Rats | Imidazoles - pharmacology | Podocytes - pathology | Rats, Sprague-Dawley | Collagen - metabolism | Animals | Proteinuria - drug therapy | Receptor, Angiotensin, Type 2 - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Podocytes - drug effects | Fibrosis | Angiotensin II Type 2 Receptor Blockers | Cell Proliferation - drug effects | Pyridines - pharmacology | Chronic Disease | Mitogen-Activated Protein Kinase 1 - metabolism | Receptors | Angiotensin | Antihypertensive drugs | Development and progression | Dosage and administration | Kidney diseases | Drug therapy | Properties
Journal Article
Trends in Cardiovascular Medicine, ISSN 1050-1738, 2015, Volume 26, Issue 3, pp. 221 - 228
Abstract Angiotensin II, an important component of renin angiotensin system, is a potent vasopressor and its actions are mostly mediated via angiotensin II... 
Cardiovascular | Heart failure | Hypertension | Renin angiotensin system | Angiotensin receptor blocker | Diabetes mellitus | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTAGONIST | CLINICAL-TRIAL | HEART-FAILURE | DIABETIC-NEPHROPATHY | HYPERTENSIVE PATIENTS | AZILSARTAN MEDOXOMIL | FIMASARTAN | OLMESARTAN | IRBESARTAN | VALSARTAN | Kidney Diseases - physiopathology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Heart Diseases - metabolism | Kidney - pathology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Receptor, Angiotensin, Type 2 - drug effects | Kidney - metabolism | Drug Interactions | Myocardium - metabolism | Receptor, Angiotensin, Type 1 - drug effects | Drug Therapy, Combination | Kidney Diseases - metabolism | Heart - physiopathology | Kidney - drug effects | Angiotensin II - metabolism | Heart Diseases - physiopathology | Kidney Diseases - drug therapy | Treatment Outcome | Angiotensin II Type 2 Receptor Blockers - adverse effects | Angiotensin II Type 2 Receptor Blockers - therapeutic use | Animals | Receptor, Angiotensin, Type 2 - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Heart - drug effects | Renin-Angiotensin System - drug effects | Heart Diseases - drug therapy | Heart | Pharmacy | Angiotensin converting enzyme | Atherosclerosis | Angiotensin | Physiological aspects | Patient compliance |